EUCTR2009-011189-27-IT进行中（未招募）不适用
Phase III prospective clinical trial: 18F-FCH/PET evaluation in early diagnosis of disease recurrence in prostate cancer - FCH_PET
ISTITUTI FISIOTERAPICI OSPITALIERI0 个研究点开始时间: 2009年3月13日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Male
入选标准
- •Previous Treatment for prostate cancer
- •Biochemical failure
- •Age > 40 years
- •Informed consent
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Age < 40 years
- •Life expectancy < 1 year
研究者
相似试验
进行中（未招募）
不适用
Phase III clinical study of PET-TC with [18f]Fluoroethyilcholine ([18f]Fech) in prostate cancer: assessment of the additional role with respec to conventional imaging techniquesMedDRA version: 14.1Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)prostate cancerEUCTR2012-004297-26-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI750
招募中
不适用
Clinical study to evaluate the usefulness of 18F-FBPA-PET for patient selection and expanding indication for BNCTHead and Neck Cancer,Malignant gliomaJPRN-UMIN000035976Southern TOHOKU BNCT Research Center20
进行中（未招募）
不适用
A new kind of scan for patients with an overactive parathyroidon familial primary hyperparathyroidismEUCTR2014-004590-16-NLMC Utrecht
已完成
不适用
18F-Choline PET/CT for patients with primary hyperparathyroidism and negative SPECT/CTprimary hyperparathyroidismoverproduction Parathyroid Hormone10033949NL-OMON40137niversitair Medisch Centrum Utrecht10
进行中（未招募）
1 期
Domestic Phase I/IIa Investigator-initiated Clinical Trials to Evaluate the Safety of 18F-PSMA-1007 in Healthy Adults and Subjects with Prostate CancerJPRN-jRCT2032210711Tateishi Ukihide13